NASDAQ:EGRX

Eagle Pharmaceuticals News Headlines

$41.56
+0.36 (+0.87 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$40.94
Now: $41.56
$41.84
50-Day Range
$39.63
MA: $43.56
$46.29
52-Week Range
$36.48
Now: $41.56
$56.16
Volume107,588 shs
Average Volume123,263 shs
Market Capitalization$549.30 million
P/E Ratio118.75
Dividend YieldN/A
Beta0.74

Headlines

Eagle Pharmaceuticals (NASDAQ EGRX) News Headlines Today

SourceHeadline
$45.67 Million in Sales Expected for Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) This Quarter$45.67 Million in Sales Expected for Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) This Quarter
americanbankingnews.com - April 10 at 3:00 AM
Zacks: Brokerages Anticipate Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) to Post $0.72 EPSZacks: Brokerages Anticipate Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) to Post $0.72 EPS
americanbankingnews.com - April 8 at 12:16 PM
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Expected to Announce Quarterly Sales of $45.67 MillionEagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Expected to Announce Quarterly Sales of $45.67 Million
americanbankingnews.com - March 24 at 9:56 AM
EGRX Mar 2021 45.000 callEGRX Mar 2021 45.000 call
in.finance.yahoo.com - March 20 at 12:58 PM
EGRX Mar 2021 50.000 putEGRX Mar 2021 50.000 put
in.finance.yahoo.com - March 20 at 12:58 PM
EGRX Jun 2021 50.000 putEGRX Jun 2021 50.000 put
in.finance.yahoo.com - March 20 at 7:58 AM
EGRX Mar 2021 65.000 callEGRX Mar 2021 65.000 call
in.finance.yahoo.com - March 20 at 7:58 AM
Is Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Trading At A 21% Discount?Is Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Trading At A 21% Discount?
finance.yahoo.com - March 3 at 9:06 AM
Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call TranscriptEagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript
msn.com - March 2 at 2:07 PM
Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings EstimatesEagle Pharmaceuticals (EGRX) Beats Q4 Earnings Estimates
finance.yahoo.com - March 2 at 9:06 AM
Earnings Preview: Eagle PharmaceuticalsEarnings Preview: Eagle Pharmaceuticals
finance.yahoo.com - March 1 at 1:55 PM
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021
finance.yahoo.com - February 22 at 6:16 PM
FDA CRLFDA CRL
benzinga.com - February 2 at 9:34 AM
FDA Rejects Eagle Pharmas Vasopressin ApplicationFDA Rejects Eagle Pharma's Vasopressin Application
msn.com - February 2 at 9:34 AM
Eagle Pharma Receives CRL From FDA On VasopressinEagle Pharma Receives CRL From FDA On Vasopressin
nasdaq.com - February 2 at 9:34 AM
Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin TrialEagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin Trial
finance.yahoo.com - February 2 at 9:34 AM
Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date PostponedEagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed
finance.yahoo.com - February 1 at 8:39 AM
Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 ConcernsEagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 Concerns
finance.yahoo.com - January 11 at 9:16 AM
Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare ConferenceEagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 6:28 PM
Eagle Pharmaceuticals, Inc.s (NASDAQ:EGRX) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
finance.yahoo.com - January 3 at 1:02 PM
Is EGRX A Good Stock To Buy Now?Is EGRX A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 11:05 PM
Eagle Pharmaceuticals’ Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for ViewingEagle Pharmaceuticals’ Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing
finance.yahoo.com - November 23 at 10:54 AM
Results: Eagle Pharmaceuticals, Inc. Beat Earnings Expectations And Analysts Now Have New ForecastsResults: Eagle Pharmaceuticals, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
nasdaq.com - November 4 at 8:38 AM
Eagle Pharmaceuticals, Inc. Just Beat EPS By 2,450%: Here's What Analysts Think Will Happen NextEagle Pharmaceuticals, Inc. Just Beat EPS By 2,450%: Here's What Analysts Think Will Happen Next
finance.yahoo.com - November 4 at 8:38 AM
Eagle Pharmaceuticals up 8% on Q3 beatEagle Pharmaceuticals up 8% on Q3 beat
seekingalpha.com - November 2 at 1:56 PM
Eagle Pharmaceuticals EPS beats by $0.88, beats on revenueEagle Pharmaceuticals EPS beats by $0.88, beats on revenue
seekingalpha.com - November 2 at 8:55 AM
Eagle Pharmaceuticals Reports Third Quarter 2020 ResultsEagle Pharmaceuticals Reports Third Quarter 2020 Results
finance.yahoo.com - November 2 at 8:55 AM
Eagle Pharmaceuticals (EGRX) Beats Q3 Earnings and Revenue EstimatesEagle Pharmaceuticals (EGRX) Beats Q3 Earnings and Revenue Estimates
finance.yahoo.com - November 2 at 8:55 AM
Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020
finance.yahoo.com - October 26 at 6:39 PM
Eagle Pharmaceuticals, Inc. (1E6.F)Eagle Pharmaceuticals, Inc. (1E6.F)
in.finance.yahoo.com - October 11 at 6:40 PM
Eagle Pharmaceuticals Inc. Regi (1E6.SG)Eagle Pharmaceuticals Inc. Regi (1E6.SG)
au.finance.yahoo.com - October 9 at 9:42 AM
Companies Are Starting to Buy Back Stock Again. Why That’s Good News.Companies Are Starting to Buy Back Stock Again. Why That’s Good News.
finance.yahoo.com - September 24 at 12:34 PM
Eagle Pharmaceuticals commences $25M accelerated share repurchaseEagle Pharmaceuticals commences $25M accelerated share repurchase
seekingalpha.com - September 24 at 7:29 AM
Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021
businesswire.com - September 24 at 1:08 AM
Eagle Pharmas TREAKISYM RTD formulation OKd in Japan; launch expected in January 2021Eagle Pharma's TREAKISYM RTD formulation OK'd in Japan; launch expected in January 2021
seekingalpha.com - September 23 at 9:53 AM
Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute ("RTD") Formulation, with Launch Expected in January 2021Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute ("RTD") Formulation, with Launch Expected in January 2021
finance.yahoo.com - September 23 at 9:52 AM
Eagle Pharmaceuticals (EGRX) Has Fallen 38% in Last One Year, Underperforms MarketEagle Pharmaceuticals (EGRX) Has Fallen 38% in Last One Year, Underperforms Market
finance.yahoo.com - September 9 at 2:24 PM
Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare ConferencesEagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences
finance.yahoo.com - September 8 at 8:04 AM
Eagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer’s DiseaseEagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer’s Disease
finance.yahoo.com - August 19 at 8:20 AM
More on Eagle Pharma Q2 earningsMore on Eagle Pharma Q2 earnings
seekingalpha.com - August 10 at 6:27 PM
Eagle Pharmaceuticals Inc (EGRX) Q2 2020 Earnings Call TranscriptEagle Pharmaceuticals Inc (EGRX) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 10 at 6:27 PM
Recap: Eagle Pharmaceuticals Q2 EarningsRecap: Eagle Pharmaceuticals Q2 Earnings
finance.yahoo.com - August 10 at 1:26 PM
Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Top EstimatesEagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Top Estimates
finance.yahoo.com - August 10 at 1:26 PM
Eagle Pharmaceuticals EPS beats by $0.34, misses on revenueEagle Pharmaceuticals EPS beats by $0.34, misses on revenue
seekingalpha.com - August 10 at 8:26 AM
Eagle Pharmaceuticals Reports Second Quarter 2020 ResultsEagle Pharmaceuticals Reports Second Quarter 2020 Results
finance.yahoo.com - August 10 at 8:26 AM
Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020
finance.yahoo.com - August 3 at 7:50 PM
Is Eagle Pharmaceuticals, Inc.s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
finance.yahoo.com - July 17 at 1:36 PM
Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
finance.yahoo.com - July 17 at 1:36 PM
CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection)CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection)
finance.yahoo.com - July 9 at 2:41 PM
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In FocusThe Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus
finance.yahoo.com - July 6 at 12:36 PM
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.